secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2024-07-12T23:59:59+00:00
Accession:  0001493152-24-027113
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Serina Therapeutics COO Tacey Viegas to retire July 15; consulting agreement extends stock options
--------------------------------------------------------------------------------

- Tacey Viegas notified retirement as COO effective July 15, 2024.
- Separation agreement provides 12 months of base salary plus $1,000/month.
- Consulting agreement extends options on 341,889 shares at $0.06 per share.
- No other compensation under consulting agreement beyond option extension.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000149315224027113/0001493152-24-027113-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000149315224027113/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-027113

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer